I

Indegene Ltd
NSE:INDGN

Watchlist Manager
Indegene Ltd
NSE:INDGN
Watchlist
Price: 487.4 INR -1.13% Market Closed
Market Cap: ₹117.1B

EV/OCF

0
Current
No historical data
Comparison unavailable

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
0
=
Enterprise Value
₹0
/
Operating Cash Flow
0

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
0
=
Enterprise Value
₹0
/
Operating Cash Flow
0

Valuation Scenarios

Indegene Ltd is trading above its industry average

If EV/OCF returns to its Industry Average (32.9), the stock would be worth ₹0 (100% downside from current price).

Statistics
Positive Scenarios
0/2
Maximum Downside
-100%
Maximum Upside
No Upside Scenarios
Average Downside
100%
Scenario EV/OCF Value Implied Price Upside/Downside
Current Multiple 0 ₹487.4
0%
Industry Average 32.9 ₹0
-100%
Country Average 23.4 ₹0
-100%

Forward EV/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward EV/OCF

Peer Comparison

All Multiples
EV/OCF
P/E
All Countries
Close
Market Cap EV/OCF P/E
IN
Indegene Ltd
NSE:INDGN
118.4B INR 0 0
US
GE Vernova LLC
NYSE:GEV
308.8B USD 0 0
UK
Eight Capital Partners PLC
F:ECS
158.4B EUR 0 0
US
China Industrial Group Inc
OTC:CIND
121B USD 45 425.5 4 020.7
NL
Nepi Rockcastle NV
JSE:NRP
102.4B ZAR 18.1 10.6
US
Fintech Ecosystem Development Corp
NASDAQ:FEXD
68.5B USD -46 271.6 38 690
US
CoreWeave Inc
NASDAQ:CRWV
58.9B USD 0 0
CH
Galderma Group AG
SIX:GALD
37.6B CHF 0 0
US
Symbotic Inc
NASDAQ:SYM
37.6B USD 39.7 -3 284.6
US
Coupang Inc
F:788
31.5B EUR 17.8 174.3
ZA
Vukile Property Fund Ltd
JSE:VKE
30.1B ZAR 17.4 6.9
P/E Multiple
Earnings Growth PEG
IN
I
Indegene Ltd
NSE:INDGN
Average P/E: 8 580.5
Not Available
17%
N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
19%
N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
C
China Industrial Group Inc
OTC:CIND
4 020.7
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
10.6
1%
10.6
US
F
Fintech Ecosystem Development Corp
NASDAQ:FEXD
38 690
N/A N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
47%
N/A
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -3 284.6 N/A N/A
US
Coupang Inc
F:788
174.3
96%
1.8
ZA
V
Vukile Property Fund Ltd
JSE:VKE
6.9
-5%
N/A

Market Distribution

Not Available
No Country distribution data available for this multiple

Indegene Ltd
Glance View

Market Cap
117.1B INR
Industry
N/A

Indegene Ltd. is an intriguing tale of how technology and healthcare can converge to redefine industry standards. Established in 1998, this Bangalore-based company has strategically positioned itself at the intersection of life sciences, digital marketing, and healthcare solutions. Indegene capitalizes on providing tailored solutions to pharmaceutical and healthcare companies, leveraging its unique expertise in analytics, research, and digital innovation. With the constant need for improved healthcare delivery and a more personalized patient experience, Indegene addresses these demands by offering a comprehensive suite of services that includes medical, marketing, and managed care solutions. It helps its clients to navigate the complexities of regulatory landscapes, optimize pharmaceutical commercialization, and harness the power of data-driven medical research. The financial engine behind Indegene's success lies in its ability to seamlessly blend domain expertise with digital prowess. The company generates revenue primarily through long-term contracts with some of the world's leading life sciences companies. By providing strategic insights and operational execution in areas such as content management, omni-channel marketing, and commercialization strategy, Indegene empowers its clients to optimize their business processes, engage more effectively with healthcare professionals, and ultimately enhance patient outcomes. Its investment in building proprietary platforms and cutting-edge technology tools has enabled it to offer scalable, efficient solutions that are both cost-effective and inherently innovative, ensuring that Indegene remains a pivotal player in the ever-evolving healthcare landscape.

INDGN Intrinsic Value
Not Available
I
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett